GetPortalImpactFactorByIdResp(projectId=1, id=3f7411823, cover=https://img.medsci.cn/images/journal/cover/2021/AVb_202109271314488230.jpg, fullname=Current Hematologic Malignancy Reports, abbr=CURR HEMATOL MALIG R, pyear=暂无数据, frequence=Quarterly, articleNumbers=465, citedSelf2015=8.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2019年中国人文章占该期刊总数量暂无数据 (2018年为暂无数据), issn=1558-8211, greenSci=https://www.greensci.net/search?kw=1558-8211, scijournal=https://www.scijournal.org/impact-factor-of-CURR-HEMATOL-MALIG-R.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.382, medsciHotlight=1.375, medsciHotlight5year=1.68064, citescore=5.1, hIndex=35, impactFactor=2.9, orgnization=Springer Science + Business Media, orgnizationUrl=, country=Germany, countryCn=德国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 4区, smallclassCas=医学 3 区, website=https://link.springer.com/journal/11899, websiteHits=2483, guideForAuthor=https://www.springer.com/medicine/internal/journal/11899#, guideForAuthorHits=193, submitWebsite=https://www.springer.com/medicine/internal/journal/11899, submitWebsiteHits=983, content=<span style="outline-color: initial; outline-style: initial;">Current Hematologic Malignancy Reports </span>provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.<div><br></div><div>This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy. <br style=""><br style="">We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.</div>, totalCites=1351, brief=CURR HEMATOL MALIG R杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=HEMATOLOGY" >HEMATOLOGY</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CURR HEMATOL MALIG R杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=3f7411823'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.32), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.27), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.67), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.258), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.31), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.25), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.337), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.382)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Hematology , rank=35/122), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=128/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=101/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=HEMATOLOGY, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1558-8211[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CURRENT HEMATOLOGIC MALIGNANCY REPORTS[ta], article_number=31, article_number_cn=0, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)